Epidemiology of sepsis: Race, sex, and chronic alcohol abuse

Clinical Infectious Diseases

Volumn 41, Issue SUPPL. 7, 2005, Pages

  Moss, Marc ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOL ABUSE; ALCOHOL INTOXICATION; CHRONIC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNE SYSTEM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RACE DIFFERENCE; SEPSIS; SEX DIFFERENCE;

ALCOHOLISM; ANIMALS; COMORBIDITY; CROSS INFECTION; ENGLAND; FRANCE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEPSIS; SEX FACTORS; UNITED STATES;

EID: 27744496229     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432003     Document Type: Conference Paper

References (77)

1. Alberti C, Brun-Buisson C, Goodman SV, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003; 168:77-84.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54.
3. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340:207-14.
4. Chalfin DM, Holbein ME, Fein AM, Carlon GC. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. JAMA 1993; 269:249-54.
5. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep 2001; 49:1-113.
6. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival and function after suspected gram-negative sepsis. JAMA 1995; 274:338-45.
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Intensive Care Med 2003; 29:530-8.
8. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-55.
9. The EPISPESIS group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30:580-8.
10. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30:589-96.
11. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcomes of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274:968-74.
12. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273:117-23.
13. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31:2332-8.
14. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-13.
15. Wenzel RP, Edmond MB. Severe sepsis-national estimates. Crit Care Med 2001; 29:1472-4.
16. Moss M, Martin GS. A global perspective on the epidemiology of sepsis. Intensive Care Med 2004; 30:527-9.
17. Baum M. The changing face of breast cancer-past, present, and future perspectives. Breast Cancer Res Treat 2002; 75:S1-5.
18. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature 2001; 410:968-73.
19. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C worldwide evaluation in severe sepsis (PROWESS) study group. N Engl J Med 2001; 344:759-62.
20. Ergul A. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. Hypertension 2000; 36:62-7.
21. East MA, Peterson ED. Understanding racial differences in cardiovascular care and outcomes: issues for the new millennium. Am Heart J 2000; 139:764-6.
22. Ness RB, Grisso JA, Klapper J, Vergona R. Racial differences in ovarian cancer risk. J Natl Med Assoc 2000; 92:176-82.
23. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000; 88:114-23.
24. Sartwell PE. Racial differences in sarcoidosis. Ann N Y Acad Sci 1976; 278:368-70.
25. Keller AZ. Anatomic sites, age attributes, and rates of sarcoidosis in US veterans. Am Rev Respir Dis 1973; 107:615-20.
26. Ries LAG, Hankey BF, Miller BA, Hartman A, Edwards BK. Cancer statistics review 1973-1988. NIH publication no. 91-2789. Bethesda, MD: National Cancer Institute, 1991.
27. Williams JF, Zimmerman JE, Wagner DP, Hawkins M, Knaus WA. African-American and white patients admitted to the intensive care unit: is there a difference in therapy and outcome? Crit Care Med 1995; 23:626-36.
28. Peterson DR, Thompson DJ, Chinn N. Ischemic heart disease prognosis: a community-wide assessment (1966-1969). JAMA 1972; 219:1423-7.
29. Horner RD, Lawler FH, Hainer BL. Relationship between patient race and survival following admission to intensive care among patients of primary care physicians. Health Serv Res 1991; 26:531-42.
30. Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF, Bernard GR. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly workshop on outcomes research. Am J Respir Crit Care Med 1999; 160:358-67.
31. Esper AM, Lewis CA, Nisbet R, Mannino DM, Moss M, Martin GS. Gender disparities in the incidence and outcome of sepsis according to source. Am J Respir Crit Care Med 2004; 169:A634.
32. Nisbet R, Lewis CA, Esper AM, Mannino DM, Moss M, Martin GS. Racial disparities in incidence and outcome of sepsis according to source. Am J Respir Crit Care Med 2004; 169:A635.
33. Nelson S, Kolls JK. Alcohol, host defence, and society. Nat Rev Immunol 2002; 2:205-9.
34. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995; 333:1058-65.
35. Adams WL, Yuan Z, Barboriak JJ, Rimm AA. Alcohol-related hospitalizations of elderly people. JAMA 1993; 270:1222-5.
36. Macgregor RR, Louria DB. Alcohol and infection. Curr Clin Top Infect Dis 1997; 17:291-315.
37. O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998; 338:592-602.
38. Rush B. An inquiry into the effects of ardent spirits upon the human body and mind. Q J Stud Alcohol 1943; 4:321-41.
39. Osler W. The principles and practices of medicine. New York: D. Appleton, 1905.
40. British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987; 62:195-220.
41. Dorff GJ, Rytel MW, Farmer SG, Scanlon G. Etiologies and characteristic features of pneumonias in a municipal hospital. Am J Med Sci 1973; 266:349-58.
42. Torres A, Serra-Batilles J, Ferer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144:312-8.
43. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 1990; 69:307-16.
44. Nolan JP. Alcohol as a factor in the illness of university service patients. Am J Med Sci 1965; 249:135-42.
45. Keller M. The language of alcohol problems. Presented at the research workshop on alcoholism, Fifth International Congress on Mental Health, Toronto, 1954.
46. Kolb D, Gunderson EKE. A longitudinal study of health risks associated with alcohol abuse in young men. Drug Alcohol Depend 1981; 8:131-41.
47. Kolb D, Gunderson EKE. Alcohol-related morbidity among older career navy men. Drug Alcohol Depend 1982; 9:181-9.
48. Fernandez-Sola J, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995; 155:1649-54.
49. Van Metre TE. Pneumococcal pneumonia treated with antibiotics: the prognostic significance of certain clinical findings. N Engl J Med 1954; 251:1048-52.
50. Ortqvist A, Hedlung J, Grillner L, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990; 3:1105-13.
51. Carpenter JL, Huang DY. Community-acquired pulmonary infections in a public municipal hospital in the 1980s. South Med J 1991; 84:299-306.
52. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29:2303-9.
53. Jurkovich GJ, Rivara FP, Gurney JG, et al. The effect of acute alcohol intoxication and chronic alcohol abuse on outcome from trauma. JAMA 1993; 270:51-6.
54. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:293-301.
55. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996; 275:50-4.
56. Moss M, Parsons PE, Steinberg KP, et al. The effects of chronic alcohol abuse on the incidence of the acute respiratory distress syndrome (ARDS) and the severity of the multiple organ dysfunction syndrome (MODS). Crit Care Med 2003; 31:869-77.
57. Licker M, De Perrot M, Spiliopoulos A, et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg 2003; 97:1558-65.
58. Slinger PD. Acute lung injury after pulmonary resection: more pieces of the puzzle. Anesth Analg 2003; 97:1555-7.
59. Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997; 157:1446-52.
60. Mason CM, Dobard E, Kolls J, et al. Effect of alcohol on bacterial translocation in rats. Alcohol Clin Exp Res 1998; 22:1640-5.
61. Napolitano LM, Koruda MJ, Zimmerman K, et al. Chronic ethanol intake and burn injury: evidence for synergistic alteration in gut and immune integrity. J Trauma 1995; 38:198-207.
62. Nelson S, Bagby G, Summer WR. Alcohol suppresses lipopolysaccharide- induced tumor necrosis factor activity in serum and lung. Life Sci 1989; 44:673-6.
63. Shellito JE, Zheng MQ, Ye P, Ruan S, Shean MK, Kolls J. Effect of alcohol consumption on host release of interleukin-17 during pulmonary infection with Klebsiella pneumoniae. Alcohol Clin Exp Res 2001; 25:872-81.
64. Stoltz DA, Nelson S, Kolls JK, et al. In vitro ethanol suppresses alveolar macrophage TNF-α during simian immunodeficiency virus infection. Am J Respir Crit Care Med 2000; 161:135-40.
65. Nelson S, Bagby G, Andreson J, et al. The effects of ethanol, tumor necrosis factor, and granulocyte colony-stimulating factor on lung antimicrobial defenses. Adv Exp Med Biol 1991; 288:245-53.
66. Boe DM, Nelson S, Zhang P, Bagby GJ. Acute ethanol intoxication suppresses lung chemokine production following infection with Streptococcus pneumoniae. J Infect Dis 2001; 184:1134-42.
67. Mandrekar P, Catalano D, Szabo G. Inhibition of lipopolysaccharide- mediated NFκB activation by ethanol in human monocytes. Int Immunol 1999; 11:1781-90.
68. Pickrell KL. The effects of alcoholic intoxication and ether anesthesia on resistance to pneumococcal infection. Johns Hopkins Med J 1938; 63:238-60.
69. Green GM, Kass EH. Factors influencing the clearance of bacteria by the lung. J Clin Invest 1964; 43:769-76.
70. Laurenzi GA, Guarneri JJ. A study of mechanisms of pulmonary resistance to infection: the relationship of bacterial clearance to ciliary and alveolar macrophage function. Am Rev Respir Dis 1966; 93:134-41.
71. Zhang Z, Bagby G, Stoltz D, Oliver P, Schwarzenberger PO, Kolls JK. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-α production in human monocytic cells. Alcohol Clin Exp Res 2001; 25:444-9.
72. Omidvari K, Casey R, Nelson S, et al. Alveolar macrophage release of tumor necrosis factor alpha in chronic alcoholics without liver disease. Alcohol Clin Exp Res 1998; 22:567-72.
73. Gluckman SJ, Dvorak VC, MacGregor RR. Host defenses during prolonged alcohol consumption in a controlled environment. Arch Intern Med 1977; 137:1539-43.
74. Coonrod JD, Lester RL, Hsu LC. Characterization of the extracellular bactericidal factors of rat alveolar lining material. J Clin Invest 1984; 74:1269-79.
75. Baughman RP, Roselle GA. Surfactant deficiency with decreased opsonic activity in a guinea pig model of alcoholism. Alcohol Clin Exp Res 1987; 11:261-4.
76. Rubins JB, Charboneau D, Prigge W, et al. Ethanol ingestion reduced anti-pneumococcal activity of rat pulmonary surfactant. J Infect Dis 1996; 174:507-12.
77. Keshavarzian A, Fields J, Vaeth J, et al. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol 1994; 89:2205-11.